Medications also differed between the groups, with patients in the kidney injury group more frequently receiving PPI, ACE inhibitors/angiotensin receptor blockers (ACEI/ARB), hypnotics, sedatives, and diuretics (Table 1). This evidence concerns the gene ACE and kidney injury.